001     288060
005     20250725100153.0
024 7 _ |a 10.1111/sms.14575
|2 doi
024 7 _ |a pmid:38339809
|2 pmid
024 7 _ |a 0905-7188
|2 ISSN
024 7 _ |a 1600-0838
|2 ISSN
024 7 _ |a altmetric:159415088
|2 altmetric
037 _ _ |a DKFZ-2024-00318
041 _ _ |a English
082 _ _ |a 796
100 1 _ |a Western, Benedikte
|0 0000-0001-7735-5254
|b 0
245 _ _ |a Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.
260 _ _ |a Oxford [u.a.]
|c 2024
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726657728_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The number of randomized controlled trials (RCTs) investigating the effects of exercise among cancer survivors has increased in recent years; however, participants dropping out of the trials are rarely described. The objective of the present study was to assess which combinations of participant and exercise program characteristics were associated with dropout from the exercise arms of RCTs among cancer survivors.This study used data collected in the Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS) study, an international database of RCTs investigating the effects of exercise among cancer survivors. Thirty-four exercise trials, with a total of 2467 patients without metastatic disease randomized to an exercise arm were included. Harmonized studies included a pre and a posttest, and participants were classified as dropouts when missing all assessments at the post-intervention test. Subgroups were identified with a conditional inference tree.Overall, 9.6% of the participants dropped out. Five subgroups were identified in the conditional inference tree based on four significant associations with dropout. Most dropout was observed for participants with BMI >28.4 kg/m2 , performing supervised resistance or unsupervised mixed exercise (19.8% dropout) or had low-medium education and performed aerobic or supervised mixed exercise (13.5%). The lowest dropout was found for participants with BMI >28.4 kg/m2 and high education performing aerobic or supervised mixed exercise (5.1%), and participants with BMI ≤28.4 kg/m2 exercising during (5.2%) or post (9.5%) treatment.There are several systematic differences between cancer survivors completing and dropping out from exercise trials, possibly affecting the external validity of exercise effects.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a cancer
|2 Other
650 _ 7 |a decision tree
|2 Other
650 _ 7 |a exercise oncology
|2 Other
650 _ 7 |a individual patient data meta-analysis
|2 Other
700 1 _ |a Ivarsson, Andreas
|b 1
700 1 _ |a Vistad, Ingvild
|b 2
700 1 _ |a Demmelmaier, Ingrid
|0 0000-0002-2068-4708
|b 3
700 1 _ |a Aaronson, Neil K
|b 4
700 1 _ |a Radcliffe, Gillian
|b 5
700 1 _ |a van Beurden, Marc
|b 6
700 1 _ |a Bohus, Martin
|b 7
700 1 _ |a Courneya, Kerry S
|b 8
700 1 _ |a Daley, Amanda J
|b 9
700 1 _ |a Galvão, Daniel A
|b 10
700 1 _ |a Garrod, Rachel
|b 11
700 1 _ |a Goedendorp, Martine M
|b 12
700 1 _ |a Griffith, Kathleen A
|b 13
700 1 _ |a van Harten, Wim H
|b 14
700 1 _ |a Hayes, Sandi C
|b 15
700 1 _ |a Herrero-Roman, Fernando
|b 16
700 1 _ |a Hiensch, Anouk E
|b 17
700 1 _ |a Irwin, Melinda L
|b 18
700 1 _ |a James, Erica
|b 19
700 1 _ |a Kenkhuis, Marlou-Floor
|b 20
700 1 _ |a Kersten, Marie José
|b 21
700 1 _ |a Knoop, Hans
|b 22
700 1 _ |a Lucia, Alejandro
|b 23
700 1 _ |a May, Anne M
|b 24
700 1 _ |a McConnachie, Alex
|b 25
700 1 _ |a van Mechelen, Willem
|b 26
700 1 _ |a Mutrie, Nanette
|b 27
700 1 _ |a Newton, Robert U
|b 28
700 1 _ |a Nollet, Frans
|b 29
700 1 _ |a Oldenburg, Hester S
|b 30
700 1 _ |a Plotnikoff, Ron
|b 31
700 1 _ |a Schmidt, Martina E
|0 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
|b 32
|u dkfz
700 1 _ |a Schmitz, Katie H
|b 33
700 1 _ |a Schulz, Karl-Heinz
|b 34
700 1 _ |a Short, Camille E
|b 35
700 1 _ |a Sonke, Gabe S
|b 36
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 37
|u dkfz
700 1 _ |a Stuiver, Martijn M
|b 38
700 1 _ |a Taaffe, Dennis R
|b 39
700 1 _ |a Thorsen, Lene
|b 40
700 1 _ |a Velthuis, Miranda J
|b 41
700 1 _ |a Wenzel, Jennifer
|b 42
700 1 _ |a Winters-Stone, Kerri M
|b 43
700 1 _ |a Wiskemann, Joachim
|0 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
|b 44
|u dkfz
700 1 _ |a Berntsen, Sveinung
|b 45
700 1 _ |a Buffart, Laurien M
|0 0000-0002-8095-436X
|b 46
773 _ _ |a 10.1111/sms.14575
|g Vol. 34, no. 2, p. e14575
|0 PERI:(DE-600)2025503-2
|n 2
|p e14575
|t Scandinavian journal of medicine & science in sports
|v 34
|y 2024
|x 0905-7188
856 4 _ |u https://inrepo02.dkfz.de/record/288060/files/Scandinavian%20Med%20Sci%20Sports%20-%202024%20-%20Western%20-%20Dropout%20from%20exercise%20trials%20among%20cancer%20survivors%20An%20individual%20patient-1.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288060/files/Scandinavian%20Med%20Sci%20Sports%20-%202024%20-%20Western%20-%20Dropout%20from%20exercise%20trials%20among%20cancer%20survivors%20An%20individual%20patient-1.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:288060
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 44
|6 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-24
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-08-24
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCAND J MED SCI SPOR : 2022
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-24
920 1 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Präventionsforschung und Krebs
|x 0
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C110-20160331
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21